Summary & Overview
HCPCS J1956: Injection, Levofloxacin 250 mg
HCPCS Level II code J1956 denotes the injectable medication levofloxacin, 250 mg. As an IV/IM antibiotic option, this code is relevant for hospital outpatient departments, emergency care, infusion centers, and other settings delivering parenteral antimicrobial therapy. Nationally, injectable antibiotics like levofloxacin are important for treating moderate to severe infections when oral administration is not feasible, and they carry implications for formulary placement, utilization management, and billing consistency across payers.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for parenteral levofloxacin, typical sites of service, and the administrative considerations tied to HCPCS coding. The publication covers standard billing practices, common modifiers used with HCPCS drugs, and expected documentation elements. It also summarizes benchmarks and policy updates relevant to drug billing and coverage at a national level, and highlights areas where providers and billing professionals typically focus attention, such as correct HCPCS usage, units billed, and setting-specific billing guidelines. Data not available in the input are noted where applicable.
Billing Code Overview
HCPCS Level II code J1956 represents the medication injection, levofloxacin, 250 mg. This code describes a single-dose injectable formulation of the antibiotic levofloxacin used for treating bacterial infections where an intravenous or intramuscular administration route is appropriate.
Service Type: Drug administration (injectable antibiotic)
Typical Site of Service: Hospital outpatient departments, emergency departments, observation units, infusion centers, and other outpatient clinical settings where parenteral antibiotics are administered.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult who presents to an outpatient infusion center, emergency department, or hospital inpatient unit with a bacterial infection requiring parenteral fluoroquinolone therapy. The clinician prescribes intravenous levofloxacin, J1956 (levofloxacin, 250 mg), when oral administration is not feasible due to vomiting, severe infection requiring high serum levels, malabsorption, or when rapid achievement of therapeutic levels is required. Common indications include community-acquired pneumonia with inability to tolerate oral intake, severe urinary tract infections complicated by pyelonephritis, intra-abdominal infections as part of combination therapy, and skin and soft tissue infections in patients with systemic symptoms.
The clinical workflow: the prescriber documents the diagnosis and orders levofloxacin 250 mg IV with route, frequency, and duration. Nursing performs medication reconciliation, verifies allergies (notably quinolone allergy), prepares and administers the IV injection or infusion per institutional policy, monitors for infusion-related reactions and QT prolongation risk, and documents lot number and administration time. Billing uses HCPCS Level II code J1956 to report the administered 250 mg injectable unit; appropriate modifiers are appended based on payer and service circumstances (e.g., no modifier for standard administration, modifier JW if partial vial discarded).
Coding Specifications
| Modifier | Description |
|---|